Evidence map›Paper›PMID 35513805›Full record

ArticleBMC public health2022

Diverging levels of COVID-19 governmental response satisfaction across middle eastern Arab countries: a multinational study.

Rania Itani, Samar Karout, Hani M J Khojah, Makram Rabah, Mohamad B Kassab, Francine K Welty, Mazen AlBaghdadi, Haitham Khraishah, Faris El-Dahiyat, Salman Alzayani and 13 more

Abstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Article
  4. Observational
  5. Article
  6. Upscaling the pharmacy profession: Knowledge and willingness of the Lebanese pharmacists to practice the administration of dermal fillers.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  7. Review
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Rania Itani *Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Samar Karout *Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Hani M J KhojahDepartment of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Madinah, Kingdom of Saudi Arabia.
Makram RabahDepartment of History and Archeology, Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon.
Mohamad B KassabDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Francine K WeltyDivision of Cardiovascular Medicine, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Mazen AlBaghdadiDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Haitham KhraishahDivision of Cardiology, University of Maryland Medical Center, Baltimore, MD, USA.
Faris El-DahiyatClinical Pharmacy Program, College of Pharmacy, Al-Ain University, Al Ain, United Arab Emirates.
Salman AlzayaniDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
Yousef S KhaderEpidemiology, Medical Education and Biostatistics, Department of Community Medicine, Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Mohammad S AlyahyaDepartment of Health Management and Policy, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Danah AlsaneDepartment of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Kuwait, Kuwait.
Rana Abu-FarhaClinical Pharmacy and Therapeutics Department, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Tareq L MukattashDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Tarek SoukariehAmerican University of Beirut Medical Center, Beirut, Lebanon.
Mohamad Fawzi AwadAmerican University of Beirut Medical Center, Beirut, Lebanon.
Reem AwadPharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Abir WehbiHealth Department, United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), Beirut, Lebanon.
Fatima AbbasPharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Hadi El MaisDepartment of Immunology, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada.
Huda El MaisFaculty of Medicine, Beirut Arab University, Beirut, Lebanon. huda.mais@hotmail.com.
Lina KaroutFaculty of Medicine, Beirut Arab University, Beirut, Lebanon. linakarout25@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPublic acceptance of governmental measures are key to controlling the spread of infectious diseases. The COVID-19 pandemic has placed a significant burden on healthcare systems for high-income countries as well as low- and middle-income countries (LMICs). The ability of LMICs to respond to the challenge of the COVID-19 pandemic has been limited and may have affected the impact of governmental strategies to control the spread of COVID-19. This study aimed to evaluate and compare public opinion on the governmental COVID-19 response of high and LMICs in the Middle East and benchmark it to international countries.

methodsAn online, self-administered questionnaire was distributed among different Middle Eastern Arab countries. Participants' demographics and level of satisfaction with governmental responses to COVID-19 were analyzed and reported. Scores were benchmarked against 19 international values.

resultsA total of 7395 responses were included. Bahrain scored highest for satisfaction with the governmental response with 38.29 ± 2.93 on a scale of 40, followed by the Kingdom of Saudi Arabia (37.13 ± 3.27), United Arab Emirates (36.56 ± 3.44), Kuwait (35.74 ± 4.85), Jordan (23.08 ± 6.41), and Lebanon (15.39 ± 5.28). Participants' country of residence was a significant predictor of the satisfaction score (P < 0.001), and participants who suffered income reduction due to the pandemic, had a history of SARS-CoV-2 infection, and held higher educational degrees had significantly lower satisfaction scores (P < 0.001). When benchmarked with other international publics, countries from the Gulf Cooperation Council had the highest satisfaction level, Jordan had an average score, and Lebanon had one of the lowest satisfaction scores.

conclusionThe political crisis in Lebanon merged with the existing corruption were associated with the lowest public satisfaction score whereas the economical instability of Jordan placed the country just before the lowest position. On the other hand, the solid economy plus good planning and public trust in the government placed the other countries of the Gulf Cooperation Council on top of the scale. Further investigation is necessary to find out how the governments of other low-income countries may have handled the situation wisely and gained the trust of their publics. This may help convey a clearer picture to Arab governments that have suffered during the pandemic.

Indexed as

COVID-19ArabsGovernmentHumansLebanonPandemicsPersonal SatisfactionSARS-CoV-2Arab countriesCOVID-19GovernmentLevel of satisfactionMiddle EastPerception

Identifiers

PMID35513805
PMCPMC9069218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.